• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效水相远程加载肽于聚(乳酸-共-乙醇酸)中。

Efficient aqueous remote loading of peptides in poly(lactic-co-glycolic acid).

机构信息

Department of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Ann Arbor, MI, 48109, USA.

Department of Biomedical Engineering, University of Michigan, 2200 Bonisteel Blvd, Ann Arbor, MI, 48109, USA.

出版信息

Nat Commun. 2022 Jun 8;13(1):3282. doi: 10.1038/s41467-022-30813-7.

DOI:10.1038/s41467-022-30813-7
PMID:35676271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9177552/
Abstract

Poly(lactic-co-glycolic acid) (PLGA) long-acting release depots are effective for extending the duration of action of peptide drugs. We describe efficient organic-solvent-free remote encapsulation based on the capacity of common uncapped PLGA to bind and absorb into the polymer phase net positively charged peptides from aqueous solution after short exposure at modest temperature. Leuprolide encapsulated by this approach in low-molecular-weight PLGA 75/25 microspheres slowly and continuously released peptide for over 56 days in vitro and suppressed testosterone production in rats in an equivalent manner as the 1-month Lupron Depot®. The technique is generalizable to encapsulate a number of net cationic peptides of various size, including octreotide, with competitive loading and encapsulation efficiencies to traditional methods. In certain cases, in vitro and in vivo performance of remote-loaded PLGA microspheres exceeded that relative to marketed products. Remote absorption encapsulation further removes the need for a critical organic solvent removal step after encapsulation, allowing for simple and cost-effective sterilization of the drug-free microspheres before encapsulation of the peptide.

摘要

聚(乳酸-共-乙醇酸)(PLGA)长效释放储库可有效延长肽类药物的作用持续时间。我们描述了一种有效的无有机溶剂远程包封方法,该方法基于未封端的 PLGA 能够在适度温度下短时间暴露后从水溶液中结合并吸收带正电荷的肽进入聚合物相中。通过这种方法包封的低分子量 PLGA 75/25 微球中的亮丙瑞林缓慢且持续地释放肽,在体外超过 56 天,并且以与 1 个月 Lupron Depot®相当的方式抑制大鼠的睾丸酮产生。该技术可推广用于包封各种大小的带正电荷的肽,包括奥曲肽,具有与传统方法相当的竞争装载和包封效率。在某些情况下,远程加载的 PLGA 微球的体外和体内性能优于市售产品。远程吸收包封进一步消除了包封后去除关键有机溶剂步骤的需要,允许在封装肽之前对无药物微球进行简单且具有成本效益的灭菌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e09/9177552/efbf6afd548b/41467_2022_30813_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e09/9177552/f6960a0a47a1/41467_2022_30813_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e09/9177552/8d7d0adcf0d3/41467_2022_30813_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e09/9177552/c511a7c4a916/41467_2022_30813_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e09/9177552/84f7df99c63b/41467_2022_30813_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e09/9177552/efbf6afd548b/41467_2022_30813_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e09/9177552/f6960a0a47a1/41467_2022_30813_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e09/9177552/8d7d0adcf0d3/41467_2022_30813_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e09/9177552/c511a7c4a916/41467_2022_30813_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e09/9177552/84f7df99c63b/41467_2022_30813_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e09/9177552/efbf6afd548b/41467_2022_30813_Fig5_HTML.jpg

相似文献

1
Efficient aqueous remote loading of peptides in poly(lactic-co-glycolic acid).高效水相远程加载肽于聚(乳酸-共-乙醇酸)中。
Nat Commun. 2022 Jun 8;13(1):3282. doi: 10.1038/s41467-022-30813-7.
2
Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release.水相远程加载模型阳离子肽于无帽聚(乳酸-共-乙醇酸)微球中用于长效控制释放。
Drug Deliv Transl Res. 2024 Mar;14(3):696-704. doi: 10.1007/s13346-023-01424-6. Epub 2023 Dec 1.
3
Aqueous remote loading of setmelanotide in poly(lactic-co-glycolic acid) microspheres for long-term obesity treatment.聚乳酸-羟基乙酸共聚物微球中远程载入黑素细胞刺激素用于长期肥胖治疗。
J Control Release. 2023 Dec;364:589-600. doi: 10.1016/j.jconrel.2023.09.015. Epub 2023 Nov 15.
4
The nature of peptide interactions with acid end-group PLGAs and facile aqueous-based microencapsulation of therapeutic peptides.肽与酸性端基聚乳酸-乙醇酸的相互作用性质及治疗性肽的简便水性微囊化。
J Control Release. 2013 Dec 28;172(3):662-70. doi: 10.1016/j.jconrel.2013.08.295. Epub 2013 Sep 8.
5
Microencapsulation of luteinizing hormone-releasing hormone agonist in poly (lactic-co-glycolic acid) microspheres by spray-drying.通过喷雾干燥法将黄体生成素释放激素激动剂包埋在聚(乳酸-共-乙醇酸)微球中。
J Control Release. 2020 May 10;321:756-772. doi: 10.1016/j.jconrel.2020.01.023. Epub 2020 Jan 11.
6
Development and characterization of composition-equivalent formulations to the Sandostatin LAR® by the solvent evaporation method.通过溶剂蒸发法开发并鉴定与善宁长效注射剂等效的制剂。
Drug Deliv Transl Res. 2022 Mar;12(3):695-707. doi: 10.1007/s13346-021-01013-5. Epub 2021 Jul 3.
7
Minimizing the initial burst of octreotide acetate from glucose star PLGA microspheres prepared by the solvent evaporation method.通过溶剂蒸发法制备的醋酸奥曲肽载 PLGA 微球中最小化初始突释。
Int J Pharm. 2022 Aug 25;624:121842. doi: 10.1016/j.ijpharm.2022.121842. Epub 2022 May 21.
8
Preparation, characterization, and pharmacodynamics of exenatide-loaded poly(DL-lactic-co-glycolic acid) microspheres.艾塞那肽聚(DL-乳酸-乙醇酸共聚物)微球的制备、表征及药效学
Chem Pharm Bull (Tokyo). 2010 Nov;58(11):1474-9. doi: 10.1248/cpb.58.1474.
9
Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide.制造变量和原材料对用于 1 个月控释亮丙瑞林的组成等效 PLGA 微球的影响。
Mol Pharm. 2020 May 4;17(5):1502-1515. doi: 10.1021/acs.molpharmaceut.9b01188. Epub 2020 Apr 6.
10
Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.微囊化方法和肽负载对聚乳酸和聚乳酸-乙醇酸共聚物体外测试期间降解的影响。
J Control Release. 1998 Feb 12;51(2-3):327-41. doi: 10.1016/s0168-3659(97)00188-0.

引用本文的文献

1
Immunosuppressive Formulations for Immunological Defense against Traumatic Brain Injury.用于创伤性脑损伤免疫防御的免疫抑制制剂。
Adv Healthc Mater. 2025 Jul;14(19):e2501417. doi: 10.1002/adhm.202501417. Epub 2025 May 29.
2
PLGA-based long-acting injectable (LAI) formulations.基于聚乳酸-羟基乙酸共聚物的长效注射剂(LAI)制剂。
J Control Release. 2025 Jun 10;382:113758. doi: 10.1016/j.jconrel.2025.113758. Epub 2025 Apr 21.
3
An active shrinkage and antioxidative hydrogel with biomimetic mechanics functions modulates inflammation and fibrosis to promote skin regeneration.

本文引用的文献

1
Development and characterization of composition-equivalent formulations to the Sandostatin LAR® by the solvent evaporation method.通过溶剂蒸发法开发并鉴定与善宁长效注射剂等效的制剂。
Drug Deliv Transl Res. 2022 Mar;12(3):695-707. doi: 10.1007/s13346-021-01013-5. Epub 2021 Jul 3.
2
Characterization of attributes and in vitro performance of exenatide-loaded PLGA long-acting release microspheres.载艾塞那肽聚乳酸-乙醇酸长效释放微球的性质表征及体外性能。
Eur J Pharm Biopharm. 2021 Jan;158:401-409. doi: 10.1016/j.ejpb.2020.10.008. Epub 2020 Oct 26.
3
Characterization of Octreotide-PLGA Binding by Isothermal Titration Calorimetry.
一种具有仿生力学功能的活性收缩和抗氧化水凝胶可调节炎症和纤维化以促进皮肤再生。
Bioact Mater. 2024 Nov 27;45:322-344. doi: 10.1016/j.bioactmat.2024.11.028. eCollection 2025 Mar.
4
Investigation of the Impact of Manufacturing Methods on Protein-Based Long-Acting Injectable Formulations: A Comparative Assessment for Microfluidics vs. Conventional Methods.制造方法对蛋白质基长效注射制剂的影响研究:微流控技术与传统方法的比较评估
Pharmaceutics. 2024 Sep 27;16(10):1264. doi: 10.3390/pharmaceutics16101264.
5
Therapeutic coordination polymers: tailoring drug release through metal-ligand interactions.治疗性配位聚合物:通过金属-配体相互作用调控药物释放
Chem Sci. 2024 Apr 11;15(19):7041-7050. doi: 10.1039/d4sc00732h. eCollection 2024 May 15.
6
Effect of PLGA raw materials on in vitro and in vivo performance of drug-loaded microspheres.聚乳酸-羟基乙酸共聚物(PLGA)原材料对载药微球体外及体内性能的影响。
Drug Deliv Transl Res. 2025 Jan;15(1):185-202. doi: 10.1007/s13346-024-01577-y. Epub 2024 Apr 20.
7
Microstructure Formation and Characterization of Long-Acting Injectable Microspheres: The Gateway to Fully Controlled Drug Release Pattern.长效注射微球的微观结构形成与表征:实现完全可控药物释放模式的途径。
Int J Nanomedicine. 2024 Feb 19;19:1571-1595. doi: 10.2147/IJN.S445269. eCollection 2024.
8
Recent Advances in the Preparation of Protein/peptide Microspheres by Solvent Evaporation Method.溶剂挥发法制备蛋白质/肽微球的最新进展。
Curr Pharm Biotechnol. 2024;25(14):1807-1817. doi: 10.2174/0113892010261032231214115415.
9
Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release.水相远程加载模型阳离子肽于无帽聚(乳酸-共-乙醇酸)微球中用于长效控制释放。
Drug Deliv Transl Res. 2024 Mar;14(3):696-704. doi: 10.1007/s13346-023-01424-6. Epub 2023 Dec 1.
10
Bioactive Suture with Added Innate Defense Functionality for the Reduction of Bacterial Infection and Inflammation.具有固有防御功能的生物活性缝线,可减少细菌感染和炎症。
Adv Healthc Mater. 2023 Dec;12(31):e2300987. doi: 10.1002/adhm.202300987. Epub 2023 Sep 21.
用等温滴定量热法研究奥曲肽-PLGA 的结合特性。
Biomacromolecules. 2020 Oct 12;21(10):4087-4093. doi: 10.1021/acs.biomac.0c00885. Epub 2020 Sep 30.
4
Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres.奥曲肽包封于市售葡萄糖-star PLGA 微球中的理化特性研究。
Mol Pharm. 2020 Nov 2;17(11):4141-4151. doi: 10.1021/acs.molpharmaceut.0c00619. Epub 2020 Oct 19.
5
Bremelanotide: First Approval.布美罗尼定:首次批准。
Drugs. 2019 Sep;79(14):1599-1606. doi: 10.1007/s40265-019-01187-w.
6
Reverse Engineering the 1-Month Lupron Depot®.反向工程 1 个月长效亮丙瑞林。
AAPS J. 2018 Oct 2;20(6):105. doi: 10.1208/s12248-018-0253-2.
7
Fc-modified exenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice.载 Fc 修饰型 exenatide 的纳米粒经口服给药以改善小鼠的降糖效果。
Sci Rep. 2018 Jan 15;8(1):726. doi: 10.1038/s41598-018-19170-y.
8
Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: In vitro evaluation.表征用于 IVIVC 开发的载亮丙瑞林醋酸酯 PLGA 微球的释放机制 I:体外评价。
J Control Release. 2016 Dec 28;244(Pt B):302-313. doi: 10.1016/j.jconrel.2016.08.023. Epub 2016 Aug 24.
9
The intracellular trafficking mechanism of Lipofectamine-based transfection reagents and its implication for gene delivery.基于脂质体转染试剂的细胞内运输机制及其在基因递送中的意义。
Sci Rep. 2016 May 11;6:25879. doi: 10.1038/srep25879.
10
Current knowledge on biodegradable microspheres in drug delivery.药物传递中可生物降解微球的现有知识。
Expert Opin Drug Deliv. 2015 Aug;12(8):1283-99. doi: 10.1517/17425247.2015.1015985. Epub 2015 Feb 17.